Q2 2026 Surgical Science Sweden AB Earnings Call Transcript
Key Points
- Revenue grew 22% reported and 25% in local currencies, exceeding financial targets.
- Adjusted EBIT margin reached 15%, in line with the financial target, with gross margin improving to 69%.
- License revenues surged 44% year-over-year, driven by strong robotics market momentum and a diverse customer base.
- Ultrasound segment grew 34%, reflecting structural adoption of point-of-care ultrasound training.
- Intuitive-related revenue loss for 2026 is now expected to be below the initial SEK60-90 million estimate due to higher dV5 attach rates and 100% renewal of My Intuitive Plus contracts.
- China remains a structural headwind due to government support for local manufacturers, impacting simulator sales.
- License and development revenues are lumpy, making quarterly performance unpredictable.
- Currency effects, particularly the weakening US dollar against the Israeli Shekel, negatively impacted results by SEK9 million in the quarter.
- Industry segment simulator sales were flat sequentially, and development revenues were weaker than the prior year.
- The reorganization of the US industry sales force may cause short-term disruptions, with benefits expected only in the second half of 2026.
Hi, everyone, and welcome to this earnings call for Surgical Science for the second quarter of 2026. My name is Tom Englund. I'm the CEO. And with me today is our CFO, Anna Ahlberg.
We'll start with a walk-through of quarter two and the numbers, and then we'll open up for questions.
Quarter two was a strong quarter, and I want to say that clearly upfront. We exceeded our financial targets on growth. Profitability was in line with our financial target, and license revenues were strong.
Revenue came in at SEK255 million, up 22% reported and 25% in local currencies. Adjusted EBIT reached SEK38 million with a margin of 15%, which is a significant recovery from quarter two last year, which was an unusually weak comparison quarter. And it's a clear sign that the actions that we have taken to improve profitability and our customer offering are working.
The gross margin improved to 69%, up from 65% in the same period last year. This reflects both the stronger mix of license revenues and the profitability
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
